Lung transplantation and bronchiolitis obliterans - An evolution in understanding

被引:9
作者
McKane, BW
Trulock, EP
Patterson, GA
Mohanakumar, T
机构
[1] Washington Univ, Sch Med, Dept Surg, Div Cardiothorac Surg, St Louis, MO 63110 USA
[2] Washington Univ, Sch Med, Dept Surg Pathol & Immunol, St Louis, MO 63110 USA
[3] Washington Univ, Sch Med, Div Pulm & Crit Care Med, Dept Med, St Louis, MO 63110 USA
关键词
lung transplantation; obliterative bronchiolitis; bronchiolitis obliterans syndrome; immunopathogenesis;
D O I
10.1385/IR:24:2:177
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Major advancements in the field of lung transplantation have occurred over the past thirty-Five years. Despite these advancements, limitations in our ability to obtain sufficient numbers of organs and in our comprehension of the problems associated with the procedure persist. The purpose of this article is to review the current understanding of both the surgical procedure and its most unfortunate complication, bronchiolitis obliterans. Even now, after over three decades of experience, this complication remains the most significant cause of morbidity and mortality following lung transplantation. This article is not meant to be an exhaustive review, and certainly there are important topics not covered herein. We have focused the discussion on ongoing studies, which attempt to understand bronchiolitis obliterans at both the clinical as well as the immunopathological level.
引用
收藏
页码:177 / 190
页数:14
相关论文
共 53 条
[11]   EXPERIMENTAL ENBLOC DOUBLE-LUNG TRANSPLANTATION [J].
DARK, JH ;
PATTERSON, GA ;
ALJILAIHAWI, AN ;
HSU, H ;
EGAN, T ;
COOPER, JD .
ANNALS OF THORACIC SURGERY, 1986, 42 (04) :394-398
[12]   Transforming growth factor beta (TGF-β) and obliterative bronchiolitis following pulmonary transplantation [J].
El-Gamel, A ;
Sim, E ;
Hasleton, P ;
Hutchinson, J ;
Yonan, N ;
Egan, J ;
Campbell, C ;
Rahman, A ;
Sheldon, S ;
Deiraniya, A ;
Hutchinson, IV .
JOURNAL OF HEART AND LUNG TRANSPLANTATION, 1999, 18 (09) :828-837
[13]   CD40 signaling replaces CD4+ lymphocytes and its blocking prevents chronic rejection of heart transplants [J].
Fischbein, MP ;
Ardehali, A ;
Yun, J ;
Schoenberger, S ;
Laks, H ;
Irie, Y ;
Dempsey, P ;
Cheng, GH ;
Fishbein, MC ;
Bonavida, B .
JOURNAL OF IMMUNOLOGY, 2000, 165 (12) :7316-7322
[14]  
GOLDBERG M, 1983, J THORAC CARDIOV SUR, V85, P821
[15]  
HARDY JD, 1963, JAMA-J AM MED ASSOC, V186, P1065
[16]  
HASEGAWA S, 1995, ARCH PATHOL LAB MED, V119, P432
[17]  
HERTZ MI, 1993, AM J PATHOL, V142, P1945
[18]   VIABILITY OF STORED LUNGS [J].
HINO, K ;
GROGAN, JB ;
HARDY, JD .
TRANSPLANTATION, 1968, 6 (01) :25-&
[19]  
Hosenpud JD, 1996, J HEART LUNG TRANSPL, V15, P655
[20]   Development of ELISA-detected anti-HLA antibodies precedes the development of bronchiolitis obliterans syndrome and correlates with progressive decline in pulmonary function after lung transplantation [J].
Jaramillo, A ;
Smith, MA ;
Phelan, D ;
Sundaresan, S ;
Trulock, EP ;
Lynch, JP ;
Cooper, JD ;
Patterson, GA ;
Mohanakumar, T .
TRANSPLANTATION, 1999, 67 (08) :1155-1161